99 related articles for article (PubMed ID: 12005241)
21. No association between a genetic variant of the p22(phox) component of NAD(P)H oxidase and the incidence and progression of IgA nephropathy.
Wolf G; Panzer U; Harendza S; Wenzel U; Stahl RA
Nephrol Dial Transplant; 2002 Aug; 17(8):1509-12. PubMed ID: 12147803
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphism of vascular endothelial growth factor: impact on progression of IgA nephropathy.
Chow KM; Szeto CC; Lai FM; Poon P; Wong TY; Li PK
Ren Fail; 2006; 28(1):15-20. PubMed ID: 16526314
[TBL] [Abstract][Full Text] [Related]
23. G protein beta3 subunit C825T polymorphism in primary IgA nephropathy.
Thibaudin L; Berthoux P; Thibaudin D; Mariat C; Berthoux F
Kidney Int; 2004 Jul; 66(1):322-8. PubMed ID: 15200440
[TBL] [Abstract][Full Text] [Related]
24. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy.
Shu KH; Lee SH; Cheng CH; Wu MJ; Lian JD
Kidney Int; 2000 Aug; 58(2):783-9. PubMed ID: 10916103
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schoenlein patients. Italian Group of Renal Immunopathology.
Amoroso A; Danek G; Vatta S; Crovella S; Berrino M; Guarrera S; Fasano ME; Mazzola G; Amore A; Gianoglio B; Peruzzi L; Coppo R
Nephrol Dial Transplant; 1998 Dec; 13(12):3184-8. PubMed ID: 9870486
[TBL] [Abstract][Full Text] [Related]
26. Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients.
Narita I; Saito N; Goto S; Jin S; Omori K; Sakatsume M; Gejyo F
Kidney Int; 2002 May; 61(5):1853-8. PubMed ID: 11967037
[TBL] [Abstract][Full Text] [Related]
27. Correlation analysis of angiotensin-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase gene polymorphisms and the progression of immunoglobulin A nephropathy/membranous nephropathy.
Zhu X; Kong D; Zhang L; Sun Y; Na S; Han C; Jin X
Hum Pathol; 2013 Dec; 44(12):2806-13. PubMed ID: 24157068
[TBL] [Abstract][Full Text] [Related]
28. IgA Nephropathy Susceptibility Loci and Disease Progression.
Shi M; Ouyang Y; Yang M; Yang M; Zhang X; Huang W; Wang W; Wang Z; Zhang W; Chen X; Pan X; Ren H; Chen N; Xie J
Clin J Am Soc Nephrol; 2018 Sep; 13(9):1330-1338. PubMed ID: 30042224
[TBL] [Abstract][Full Text] [Related]
29. Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.
Merta M; Reiterová J; Tesar V; Stekrová J; Viklický O
Ren Fail; 2002 Sep; 24(5):585-93. PubMed ID: 12380903
[TBL] [Abstract][Full Text] [Related]
30. [Uteroglobin G38A polymorphism is associated with the progression of IgA nephropathy in Chinese patients].
Lü JC; Zhang H; Chen YQ; Liu G; Wang HY
Zhonghua Nei Ke Za Zhi; 2004 Jan; 43(1):37-40. PubMed ID: 14990020
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy.
Syrjänen J; Huang XH; Mustonen J; Koivula T; Lehtimäki T; Pasternack A
Nephron; 2000 Oct; 86(2):115-21. PubMed ID: 11014979
[TBL] [Abstract][Full Text] [Related]
32. Genetic factors in IgA nephropathy.
Schmidt S; Ritz E
Ann Med Interne (Paris); 1999 Feb; 150(2):86-90. PubMed ID: 10392256
[TBL] [Abstract][Full Text] [Related]
33. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients.
Zhou TB; Yin SS; Liang R
J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):235-41. PubMed ID: 23060471
[TBL] [Abstract][Full Text] [Related]
34. CC-chemokine receptor five gene polymorphism in primary IgA nephropathy: the 32 bp deletion allele is associated with late progression to end-stage renal failure with dialysis.
Berthoux FC; Berthoux P; Mariat C; Thibaudin L; Afiani A; Linossier MT
Kidney Int; 2006 Feb; 69(3):565-72. PubMed ID: 16395252
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of IgA nephropathy.
Wada J; Sugiyama H; Makino H
Semin Nephrol; 2003 Nov; 23(6):556-63. PubMed ID: 14631563
[TBL] [Abstract][Full Text] [Related]
36. Gender specific association of aldosterone synthase gene polymorphism with renal survival in patients with IgA nephropathy.
Song J; Narita I; Goto S; Saito N; Omori K; Sato F; Ajiro J; Saga D; Kondo D; Sakatsume M; Gejyo F
J Med Genet; 2003 May; 40(5):372-6. PubMed ID: 12746403
[No Abstract] [Full Text] [Related]
37. ACE genotype and progression of IgA nephropathy.
Fukushima T; Nomura S; Kawai S; Osawa G
Lancet; 1995 Aug; 346(8974):571. PubMed ID: 7658790
[No Abstract] [Full Text] [Related]
38. The chemokine receptor 5 Delta32 mutation is associated with increased renal survival in patients with IgA nephropathy.
Panzer U; Schneider A; Steinmetz OM; Wenzel U; Barth P; Reinking R; Becker JU; Harendza S; Zahner G; Fischereder M; Krämer BK; Schlöndorff D; Ostendorf T; Floege J; Helmchen U; Stahl RA
Kidney Int; 2005 Jan; 67(1):75-81. PubMed ID: 15610230
[TBL] [Abstract][Full Text] [Related]
39. No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy.
Steinmetz OM; Panzer U; Harendza S; Mertens PR; Ostendorf T; Floege J; Helmchen U; Stahl RA
Nephrol Dial Transplant; 2004 Mar; 19(3):596-601. PubMed ID: 14767014
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism in promoter region of Fcalpha receptor gene in patients with IgA nephropathy.
Tsuge T; Shimokawa T; Horikoshi S; Tomino Y; Ra C
Hum Genet; 2001 Feb; 108(2):128-33. PubMed ID: 11281451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
